Metallothionein-I + II and receptor megalin are altered in relation to oxidative stress in cerebral lymphomas

References

• Algazi AP, Kadoch C, Rubenstein JL. Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics 2009;6:587–597.
   PubMed Web of Science ®Google Scholar
• Morris PG, Abrey LE. Therapeutic challenges in primary CNS lymphoma. Lancet Neurol 2009;8:581–592.
   PubMed Web of Science ®Google Scholar
• Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol 2006;24:1281–1288.
   PubMed Web of Science ®Google Scholar
• Mohile NA, Abrey LE. Primary central nervous system lymphoma. Semin Radiat Oncol 2007;17:223–229.
   PubMed Web of Science ®Google Scholar
• Hunt KE, Reichard KK. Diffuse large B-cell lymphoma. Arch Pathol Lab Med 2008;132:118–124.
   PubMed Web of Science ®Google Scholar
• Pedersen MØ, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 2009;44:29–64.
   PubMed Web of Science ®Google Scholar
• Sjö LD, Poulsen CB, Hansen M, Møller MB, Ralfkiaer E. Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups. Eur J Haematol 2007;79:501–507.
   PubMed Web of Science ®Google Scholar
• Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med 2008;132:441–461.
   PubMed Web of Science ®Google Scholar
• Mrugala MM, Rubenstein JL, Ponzoni M, Batchelor TT. Insights into the biology of primary central nervous system lymphoma. Curr Oncol Rep 2009;11:73–80.
   PubMedGoogle Scholar
• DeAngelis LM. Primary central nervous system lymphoma: coming or going? Blood 2009;113:4483–4484.
   PubMed Web of Science ®Google Scholar
• Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. Oncologist 2009;14:526–539.
   PubMed Web of Science ®Google Scholar
• Hochberg FH, Baehring JM, Hochberg EP. Primary CNS lymphoma. Nat Clin Pract Neurol 2007;3:24–35.
   PubMedGoogle Scholar
• Poulsen CB, Borup R, Borregaard N, Nielsen FC, Møller MB, Ralfkiaer E. Prognostic significance of metallothionein in B-cell lymphomas. Blood 2006;108:3514–3519.
   PubMed Web of Science ®Google Scholar
• Yang M, Chitambar CR. Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells. Free Radic Biol Med 2008;45:763–772.
   PubMed Web of Science ®Google Scholar
• Penkowa M, Sørensen BL, Nielsen SL, Hansen PB. Metallothionein as a useful marker in Hodgkin lymphoma subclassification. Leuk Lymphoma 2009;50:200–210.
   PubMed Web of Science ®Google Scholar
• Penkowa M, Espejo C, Ortega-Aznar A, et al Metallothionein expression in the central nervous system of multiple sclerosis patients. Cell Mol Life Sci 2003;60:1258–1266.
   PubMed Web of Science ®Google Scholar
• Scheede Bergdahl C, Penkowa M, Hidalgo J, Olsen DB, Boushel R, Dela F. Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 2005;54:3089–3094.
   PubMed Web of Science ®Google Scholar
• McCann KJ, Ashton-Key M, Smith K, Stevenson FK, Ottensmeier CH. Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood 2009;113:4677–4680.
   PubMed Web of Science ®Google Scholar
• Camilleri-Broët S, Martin A, Moreau A, et al Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS). Am J Clin Pathol 1998;110:607–612.
   PubMed Web of Science ®Google Scholar
• Diamond C, Taylor TH, Aboumrad T, Anton-Culver H. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 2006;106:128–135.
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Izumoto S, Hashimoto N, et al Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomas. Brain Tumor Pathol 2008;25:73–78.
   PubMed Web of Science ®Google Scholar
• Robertus JL, Harms G, Blokzijl T, et al Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Mod Pathol 2009;22:547–555.
   PubMed Web of Science ®Google Scholar
• Nielsen AE, Bohr A, Penkowa M. The balance between life and death of cells: roles of metallothioneins. Biomark Insights 2007;2:99–111.
   Google Scholar
• Pedersen MØ, Larsen A, Stoltenberg M, Penkowa M. Cell death in the injured brain: roles of metallothioneins. Prog Histochem Cytochem 2009;44:1–27.
   PubMed Web of Science ®Google Scholar
• Penkowa M. Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J 2006;273:1857–1870.
   PubMed Web of Science ®Google Scholar
• Chung RS, Hidalgo J, West AK. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J Neurochem 2008;104:14–20.
   PubMed Web of Science ®Google Scholar
• Bhagavathi S, Sharathkumar A, Hunter S, et al Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas. Clin Neuropathol 2008;27:13–20.
   PubMed Web of Science ®Google Scholar
• Poulsen CB, Borup R, Nielsen FC, et al Microarray-based classification of diffuse large B-cell lymphoma. Eur J Haematol 2005;74:453–465.
   PubMed Web of Science ®Google Scholar
• Chung RS, Penkowa M, Dittmann J, et al Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem 2008;283:15349–15358.
   PubMed Web of Science ®Google Scholar
• Dutsch-Wicherek M, Sikora J, Tomaszewska R. The possible biological role of metallothionein in apoptosis. Front Biosci 2008;13:4029–4038.
   PubMed Web of Science ®Google Scholar
• Yang M, Kroft SH, Chitambar CR. Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate. Mol Cancer Ther 2007;6:633–643.
   PubMed Web of Science ®Google Scholar
• Thirumoorthy N, Manisenthil Kumar KT, Shyam Sundar A, Panayappan L, Chatterjee M. Metallothionein: an overview. World J Gastroenterol 2007;13:993–996.
   PubMed Web of Science ®Google Scholar
• Miyashita H, Sato Y. Metallothionein 1 is a downstream target of vascular endothelial zinc finger 1 (VEZF1) in endothelial cells and participates in the regulation of angiogenesis. Endothelium 2005;12:163–170.
   PubMed Web of Science ®Google Scholar
• Cherian MG, Kang YJ. Metallothionein and liver cell regeneration. Exp Biol Med (Maywood) 2006;231:138–144.
   PubMed Web of Science ®Google Scholar
• Ostrakhovitch EA, Olsson PE, Jiang S, Cherian MG. Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 2006;580:1235–1238.
   PubMed Web of Science ®Google Scholar
• Theocharis SE, Margeli AP, Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers 2003;18:162–169.
   PubMed Web of Science ®Google Scholar
• Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP. Metallothionein expression in human neoplasia. Histopathology 2004;45:103–118.
   PubMed Web of Science ®Google Scholar
• Faurschou M, Penkowa M, Andersen CB, Starklint H, Jacobsen S. The renal metallothionein expression profile is altered in human lupus nephritis. Arthritis Res Ther 2008;10:R76.
   PubMed Web of Science ®Google Scholar
• Ambjørn M, Asmussen JW, Lindstam M, et al Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J Neurochem 2008;104:21–37.
   PubMed Web of Science ®Google Scholar
• Pedersen MØ, Jensen R, Pedersen DS, et al Metallothionein-I + II in neuroprotection. Biofactors 2009;35:315–325.
   PubMed Web of Science ®Google Scholar
• Sauerbrey A, Zintl F, Volm M. Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol 1994;69:111–115.
   PubMed Web of Science ®Google Scholar
• Volm M, Zintl F, Edler L, Sauerbrey A. Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1997;28:117–126.
   PubMedGoogle Scholar
• Fitzgerald M, Nairn P, Bartlett CA, Chung RS, West AK, Beazley LD. Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp Brain Res 2007;183:171–180.
   PubMed Web of Science ®Google Scholar
• Chung RS, Hidalgo J, West AK. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J Neurochem 2008;104:14–20.
   PubMed Web of Science ®Google Scholar